Publication: SEOM clinical guideline in nasopharynx cancer (2017).
Loading...
Identifiers
Date
2017-11-02
Authors
Pastor, M
Lopez Pousa, A
Del Barco, E
Perez Segura, P
Astorga, B Gonzalez
Castelo, B
Bonfill, T
Martinez Trufero, J
Grau, J Jose
Mesia, R
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Export
Abstract
Nasopharyngeal carcinoma (NPC) is distinct from other cancers of the head and neck in biology, epidemiology, histology, natural history, and response to treatment. Radiation therapy is an essential component of curative-intent of non-disseminated disease and the association of chemotherapy improves the rates of survival. In the case of metastatic disease stages, treatment requires platinum/gemcitabine-based chemotherapy and patients may achieve a long survival time.
Description
MeSH Terms
Carcinoma
Humans
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
Humans
Nasopharyngeal Carcinoma
Nasopharyngeal Neoplasms
DeCS Terms
CIE Terms
Keywords
Locally-advanced disease, Nasopharynx cancer, Recurrent/metastatic disease, Treatment guidelines